{
 "PrintNo":"S9020","Session":2019,"Chamber":"SENATE","BillType":"Senate","Published":"2020-10-02T14:55:25.807334Z",
 "Status":"IN_SENATE_COMM","Committee":"Rules",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2020-10-02","Committee":"Rules"}],
 "Actions":[{"Text":"REFERRED TO RULES","Date":"2020-10-02","Chamber":"SENATE"}],
 "Sponsors":[{"ID":377,"Name":"Gustavo Rivera","Short":"RIVERA"}],
 "Title":"Relates to enacting the \"New York affordable drug manufacturing act of 2020\"",
 "Summary":"Enacts the \"New York affordable drug manufacturing act of 2020\" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.",
 "LawSection":"Public Health Law","LawCode":"Add Art 2-A Title 4 §§282 - 285, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to enacting the \"New York affordable drug manufacturing act of 2020\""
}